Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matria Healthcare (MATR) -- Ignore unavailable to you. Want to Upgrade?

To: Gregory Cole Brock who wrote (99)	12/30/1997 8:39:00 PM
From: GREATMOOD	Read Replies (1) \| Respond to of 220

Greg, In Matria's case, I think TA should stand for tax analysis. Matria, along with hundreds of other smaller cap stocks, has lost it's liquidity. Anybody who wanted out at the end of the year for whatever reason had to take an eighth lower, another eighth lower, etc. We seem to have had pretty good support at 5, but I sure hope we don't test it again. A lot of buyers seemed to have stepped aside the last couple of weeks while the end of the year crowd finished up their selling. Hopefully the tax related selling is all done. Today the buyers stepped up with some decent upside volume. One of the catalysts responsible for today's action is a quite positive RED CHIP REVUE update on Matria dated 12/22/97. They speak very favorably about Matria's balance sheet, their margins, their entry into the growing Fertility field, their new venture into the diabetes field, etc. They put a price target of $10 dollars a share in 98. Keep in touch, GM